Affiliation: Federal University of São Paulo and Federal University of São Paulo, Federal University of Latin American Integration and Cellavita Pesquisas Científicas Ltda.

Dr. Rodrigo Araldi has a degree in Biology from the São Paulo State University (UNESP, Brazil). He completed his Master and Ph.D. in Biotechnology from the University of São Paulo (USP, Brazil) and a post-doc trainee in Cancer Molecular Biology at Paulista School of Medicine from São Paulo Federal University of São Paulo (UNIFESP, Brazil). He has more than 16 years of experience with cancer biology and genetics, with emphasis on cancer metastasis and epithelial-mesenchymal transition. Dr. Araldi has served as a Professor of oncogenetic and innovative technologies for cancer treatment at São Paulo Federal University (UNIFESP) and the Federal University of Latin American Integration. He has also served as Chief of Science and Innovation in the Cellavita Pesquisas Científicas, a Brazilian novel venture dedicated to developing disruptive technologies for neurodegenerative disorders and cancer. Currently, his efforts are focused on studying the role of exosomes in cancer metastasis, as well as to biotechnologically explore these extracellular vesicles for cancer treatment (cell-free therapy).